Cronos (CRON) Share-based Compensation (2019 - 2026)
Cronos' (CRON) quarterly Share-based Compensation came in at $1.3 million in Q1 2026, down 55.19% year-on-year from $2.9 million in Q1 2025, and up 119.57% quarter-over-quarter from $598000.0 in Q4 2025.
Cronos (CRON) Share-based Compensation (2019 - 2026) Analysis & Trends
Cronos' Share-based Compensation history runs 8 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- On a quarterly basis, Share-based Compensation fell 55.19% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $2.1 million, a 0.56% decrease from a year earlier, with the FY2025 full-year figure at $3.8 million, up 204.71% from the prior year.
- Share-based Compensation climbed to $1.3 million in Q1 2026 per CRON's latest filing, from $598000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $8.5 million in Q3 2022 and bottomed at -$7.7 million in Q4 2022.
- The 5-year median for Share-based Compensation is $1.3 million (2026), against an average of $597294.1.
- Biggest YoY gain for Share-based Compensation was 528.46% in 2022; the steepest drop was 155.3% in 2022.
- Year by year, Share-based Compensation stood at -$7.7 million in 2022, then advanced by 24.92% to -$5.8 million in 2023, then increased by 9.09% to -$5.3 million in 2024, then jumped by 111.32% to $598000.0 in 2025, then jumped by 119.57% to $1.3 million in 2026.
- Per Business Quant, the three latest CRON Share-based Compensation figures stand at $1.3 million (Q1 2026), $598000.0 (Q4 2025), and -$316000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | 1.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.31 Mn |
| Mar 31, 2026 | 1.31 Mn |
| Dec 31, 2025 | 598,000.00 |
| Dec 31, 2025 | 598,000.00 |
| Sep 30, 2025 | -316,000.00 |
| Sep 30, 2025 | -316,000.00 |
| Jun 30, 2025 | 539,000.00 |
| Jun 30, 2025 | 539,000.00 |
| Mar 31, 2025 | 2.93 Mn |
| Mar 31, 2025 | 2.93 Mn |
| Dec 31, 2024 | -5.28 Mn |
| Dec 31, 2024 | -5.28 Mn |
| Sep 30, 2024 | 5.61 Mn |
| Sep 30, 2024 | 5.61 Mn |
| Jun 30, 2024 | -1.11 Mn |
| Jun 30, 2024 | -1.11 Mn |
| Mar 31, 2024 | 2.02 Mn |
| Mar 31, 2024 | 2.02 Mn |
| Dec 31, 2023 | -5.81 Mn |
| Dec 31, 2023 | -5.81 Mn |